INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Targeted Protein Degraders: Transforming Oral Therapeutics
CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
-
7 Practical Implications Of ICH E6(R3) For Early-Phase Trial Design
A risk-based quality approach can enhance participant protection, data integrity, and development success through focused oversight, strong governance, and clear documentation.
-
Critical Imaging Risks In GLP-1 And Neurology Studies
In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.
-
The Triple Effect Of Community-Based Clinical Trials
Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.
-
The Rise Of Targeted Modalities In Pharmaceutical Development8/11/2025
Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.
-
Site Engagement Doesn't Start At First Patient In7/15/2025
Site engagement starts long before enrollment. Explore how well-designed investigator meetings can set the tone, build trust, and give site teams the momentum they need to deliver.
-
Advanced Drug Delivery And Drug Device Combination Product Solutions7/17/2025
PCI Pharma Services' end-to-end injectable services, comprehensive approach, and dedication to excellence provide convenient, easy-to-use, patient-centric therapies.
-
Your IRB, Simplified: Fast, Friendly, And Focused7/21/2026
IRB approval does not have to be defined by delays or confusion. Learn how expert guidance, regulatory support, and modern technology can help research teams move forward with greater efficiency.
-
5 Outdated Practices Holding Back Modern Bioanalysis10/20/2025
Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Maximize growth with strategic site selection and incentives advisory that help reduce project costs and optimize expansion, unlocking long-term business value.
-
From enabling connected clinical trials to supporting digital therapy management, our solutions help improve clinical trial operational efficiency and data quality, strengthen commercial success, and empower patients to self-manage their therapy.
-
Accelerate trials with a centralized digital workspace that replaces manual documents, boosts collaboration, supports remote access, ensures compliance, and provides real-time visibility.
-
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.